---
title: "Wai Chun Bio-Technology Halts Trading Pending Inside Information Announcement"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282471815.md"
description: "Wai Chun Bio-Technology Ltd. has requested a one-day trading halt on the Hong Kong Stock Exchange, effective from 9:00 a.m. on 13 April 2026, pending the release of an announcement containing inside information. This indicates a potentially material development for shareholders and market participants. Investors are awaiting clarity on how this undisclosed matter may impact the company's operations, governance, or financial outlook. Wai Chun Bio-Technology is a Hong Kong-listed company with a market cap of HK$45.51M, led by Chairman and CEO Lam Ka Chun."
datetime: "2026-04-13T01:37:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282471815.md)
  - [en](https://longbridge.com/en/news/282471815.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282471815.md)
---

# Wai Chun Bio-Technology Halts Trading Pending Inside Information Announcement

### Claim 30% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

The latest announcement is out from Wai Chun Bio-Technology Ltd. ( (HK:0660) ).

Wai Chun Bio-Technology Limited has requested a one-day trading halt in its shares on the Hong Kong Stock Exchange, effective from 9:00 a.m. on 13 April 2026. The suspension is pending the release of an announcement containing inside information, signaling that a potentially material development is forthcoming for shareholders and other market participants.

The move indicates that the company is preparing to disclose price-sensitive information that could affect its valuation or strategic direction. Investors will closely watch the upcoming announcement for clarity on how the undisclosed matter may influence the company’s operations, governance, or financial outlook, and the brief duration suggests a near-term resolution.

**More about Wai Chun Bio-Technology Ltd.**

Wai Chun Bio-Technology Limited is a Hong Kong-listed company incorporated in the Cayman Islands and traded on the Stock Exchange of Hong Kong under stock code 660. The board is led by Chairman and Chief Executive Officer Lam Ka Chun and includes three independent non-executive directors, underscoring a standard corporate governance structure for a small to mid-cap listed firm.

**Average Trading Volume:** 164,636

**Technical Sentiment Signal:** Buy

**Current Market Cap:** HK$45.51M

### Related Stocks

- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [00660.HK](https://longbridge.com/en/quote/00660.HK.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)

## Related News & Research

- [Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand](https://longbridge.com/en/news/286665358.md)
- [Manulife Singapore to offer multi-cancer blood test starting May](https://longbridge.com/en/news/286710691.md)
- [Fingerprint Cards AB Bets on Merger-Led Turnaround](https://longbridge.com/en/news/286333864.md)
- [20:03 ETHarbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate](https://longbridge.com/en/news/286688082.md)
- [HBM Holdings Says Director Probed by CSRC, Sees No Impact on Operations](https://longbridge.com/en/news/286197909.md)